Qube Research & Technologies (QRT)
PYXS icon

Qube Research & Technologies (QRT)’s Pyxis Oncology PYXS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.5K Sell
11,286
-134,527
-92% -$203K ﹤0.01% 3291
2025
Q4 		$168K Buy
145,813
+115,005
+373% +$406K ﹤0.01% 3089
2025
Q3 		$68.4K Sell
30,808
-72,255
-70% -$104K ﹤0.01% 3132
2025
Q2 		$113K Buy
103,063
+57,935
+128% +$65.3K ﹤0.01% 3017
2025
Q1 		$44.2K Buy
45,128
+20,604
+84% +$27.5K ﹤0.01% 3132
2024
Q4 		$38.3K Sell
24,524
-48,363
-66% -$139K ﹤0.01% 3131
2024
Q3 		$267K Buy
72,887
+4,875
+7% +$17.1K ﹤0.01% 2469
2024
Q2 		$225K Sell
68,012
-84,994
-56% -$357K ﹤0.01% 2396
2024
Q1 		$652K Buy
153,006
+153,004
+7,650,200% +$643K ﹤0.01% 2395
2023
Q4 		$4 Hold
2
– – ﹤0.01% 4219
2023
Q3 		$4 Buy
+2
New +$5 ﹤0.01% 3978

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PYXS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Pyxis Oncology (PYXS) stake by 92% in Q1 2026, selling an estimated $203K and leaving 11,286 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3291.

Qube Research & Technologies (QRT) first reported a position in PYXS in Q3 2023 and has held it in 11 quarters since. The position peaked at $652K in Q1 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 11,286 shares of Pyxis Oncology worth $16.5K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 134,527 Pyxis Oncology shares in Q1 2026, an estimated $203K.
  • Pyxis Oncology made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3291 holding.
  • Qube Research & Technologies (QRT) first reported a position in Pyxis Oncology in Q3 2023 and has held it in 11 quarters since.
  • Qube Research & Technologies (QRT)'s Pyxis Oncology position peaked at $652K in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.